Meanwhile, there were no significant differences in the annual rates of change between participants with vs without other vascular risk factors (hypertension, dyslipidemia, smoking), positivity for other CSF biomarkers (p-tau181 and t-tau), and APOE ε4 status (eFigure 4 in Supplement 1). This evidence concerns the gene APOE and metabolic syndrome.